Skip to main content

Find Clinical Trials

Home
Conditions
Chronic Cough

Clinical trial condition

Chronic Cough

Explore clinical trials studying Chronic Cough. Study availability and eligibility vary by location and protocol.

105 public trials 23 recruiting studies

Refine in advanced search Browse all conditions

Chronic Cough trial results

Completed

An 8-Week Refractory Chronic Cough Study (MK-7264-021)

NCT02612623

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
Locations: Afferent Investigative Site Mission Viejo, California, United States

Afferent Investigative Site San Jose, California, United States

Afferent Investigative Site Colorado Springs, Colorado, United States

Afferent Investigative Site Largo, Florida, United States

View Trial Details

Completed

Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)

NCT03482713

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Nagoya City University Hospital ( Site 3328) Nagoya, Aichi-ken, Japan

Idaimae Minamiyojo Int Clinic ( Site 3321) Sapporo, Hokkaido, Japan

Tsumura Cardiovascular-internal-medicine Clinic ( Site 3314) Kakogawa, Hyōgo, Japan

Hitachi, Ltd. Hitachinaka General Hospital ( Site 3301) Hitachi-Naka, Ibaraki, Japan

View all 16 locations

View Trial Details

Completed

Efficacy, Safety and Palatability of the Syrup "KalobaTuss® Children" for the Treatment of Cough in Children

NCT04073251

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Gioacchino Calapai Messina, Me, Italy

View Trial Details

Completed

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

NCT03773068

Conditions: Biological Availability, Chronic Cough, Cough, +11 more
Locations: PRAHealthSciences Groningen, Netherlands

View Trial Details

Completed

Hull Airway Reflux Questionnaire Scores Following Cough Treatment

NCT01515280

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Hull and East Yorkshire Hospitals Trust Cottingham, East Riding Of Yorkshire, United Kingdom

View Trial Details

Completed

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

NCT03622216

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: BioSolutions Clinical Research Center La Mesa, California, United States

Allergy & Asthma Associates of Southern California Mission Viejo, California, United States

Asthma and Allergy Associates Colorado Springs, Colorado, United States

Storms Clinical Research Institute Colorado Springs, Colorado, United States

View all 17 locations

View Trial Details

Completed

Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)

NCT02476890

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
Locations: Not specified

View Trial Details

Completed

Cough in Eastern and Central Finland

NCT03639727

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Kuopio University Hospital Kuopio, Finland

View Trial Details

Completed

Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough

NCT02797756

Conditions: Chronic Cough, Chronic Cough (CC), Cough, +12 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects

NCT01494636

Conditions: Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +4 more
Locations: GSK Investigational Site Manchester, United Kingdom

View Trial Details